Today, Monsanto filed its reply brief to the Supreme Court in support of its petition for review of the Hardeman decision.
Bayer today released the following statement on the verdict in the Clark trial in the Superior Court of California, County of Los Angeles.
Several organizations have filed amici briefs in support of Monsanto’s petition to the Supreme Court for review of the Hardeman decision.
On September 20, 2021, Monsanto filed a petition for review of the Pilliod decision with the California Supreme Court.
On June 4, 2021, Monsanto filed its appellee brief in the Carson appeal in the U.S. Court of Appeals for the 11th Circuit.
On May 18, 2021, the U.S. Environmental Protection Agency (EPA) filed a brief in Natural Resources Defense Council et al. v. United States Environmental Protection Agency in the Ninth Circuit Court of Appeals reaffirming its interim decision on glyphosate.
On April 7, 2021, plaintiffs’ class counsel in the Roundup™ multi-district litigation filed a reply to the Motion for Preliminary Approval.
On September 28, 2020, Monsanto filed a reply to the Plaintiff’s answer to the company’s Petition for Review with the California Supreme Court.
Multiple amicus letters have been filed in support of Monsanto’s petition for review of the Johnson case before the California Supreme Court.
Monsanto filed a petition with the highest court in California seeking its review of the decision in Dewayne Johnson v. Monsanto Company, the first case in the Roundup™ litigation to go to trial. Monsanto asserts in the petition that the Court of Appeal’s recent decision warrants review because it conflicts with the law and longstanding legal principles with regard to federal preemption, design defect, failure to warn and punitive damages.
Bayer today provided an update on its five-point plan to address future Roundup™ litigation risk after its May 27th decision to withdraw from the national class process. The company is now in more control of important aspects of the risk mitigation process and has sketched out two basic scenarios going forward to provide a path to closure of this litigation. The first scenario is based on obtaining a favorable decision by the United States Supreme Court on a cross-cutting issue like federal preemption which would effectively and largely end the U.S. Roundup™ litigation. The second scenario assumes that the Supreme Court either declines to hear the Hardeman case or issues a ruling in favor of plaintiff – in that case the company would activate its own claims administration program.
Read about the five-point plan here.